The Health Gains of Weight Loss: GLP-1 Receptor Agonists for Comprehensive, Long-Term Management of Obesity and Its Comorbidities

5 episodes

0.50 program credits

35m

Details

Episodes

Presenters

Overview
This 5-part series redefines obesity as a chronic, biologically driven disease. It addresses the impact of stigma, the management of common comorbidities, and the full spectrum of treatment options—from lifestyle interventions to GLP-1 receptor agonists and bariatric surgery. Practical guidance, patient cases, and expert insights help primary care providers deliver respectful, effective, and sustainable obesity care.
This program has been put together in collaboration with Sarah le Brocq - Founder of organization All About Obesity CIC – www.allaboutobesity.org
Disclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, MEDCON International requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs. -
Faculty:
Barbara McGowan, PhD, MBBS
Professor of Endocrinology and Diabetes
Guy's and St Thomas' NHS Foundation Trust
London, United Kingdom
Professor McGowan has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Research: Novo Nordisk
Ownership: Reset Health
Consulting Fee: AstraZeneca, Boehringer Ingelheim Pharmaceuticals, Inc., Lilly, Novo Nordisk
Michael Crotty, MB, BCh, BAO
GP Specialist in Obesity Medicine
My Best Weight Clinic
Greystones, Ireland
Dr. Crotty has reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months:
Consulting Fees: Johnson & Johnson, Novo Nordisk
Ana Maria Cebrián Cuenca, MD, PhD
Family Doctor
Cartagena Casco Health Center
Cartagena, Spain
Dr. Cebrián Cuenca has no relevant relationships to disclose.
Reviewers/Content Planners/Authors:
Cindy Davidson has no relevant relationships to disclose.
Anja Gerriits has no relevant relationships to disclose.
Brian P. McDonough, MD, FAAFP, has no relevant relationships to disclose.
Learning Objectives
After participating in this educational activity, participants should be better able to:
Discuss the role of GLP-1RAs in addressing the underlying pathophysiological mechanisms of obesity as a chronic, multifactorial disease
Evaluate the latest clinical evidence for the efficacy and safety of GLP-1RAs in managing obesity and its related complications
Develop strategies for delivering evidence-based obesity care, including pharmacotherapy
Target Audience
This activity has been designed to meet the educational needs of primary care physicians and general practitioners as well as all other physicians, physician assistants, nurse practitioners, nurses, pharmacists, and healthcare providers involved in managing patients with obesity.
Accreditation and Credit Designation Statements
The European Board for Accreditation of Continuing Education for Health Professionals (EBAC®) holds an agreement on mutual recognition of substantive equivalency with the US Accreditation Council for CME (ACCME) and the Royal College of Physicians and Surgeons of Canada, respectively.
EBAC® is a member of the International Academy for CPD Accreditation (IACPDA) and a partner member of the International Association of Medical Regulatory Authorities (IAMRA).
This enduring activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC) for 30 minutes of effective education time.
Provider(s)/Educational Partner(s)

Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education. We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice.
Commercial Support
This activity is supported by an independent educational grant from Novo Nordisk.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Medcon. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to access a site outside of Medcon you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

Reproduction Prohibited
Reproduction of this materialis not permitted without written permission from the copyright owner.
System Requirements
- Supported Browsers (2 most recent versions):
- Google Chrome for Windows, Mac OS, iOS, and Android
  Apple Safari for Mac OS and iOS
  Mozilla Firefox for Windows, Mac OS, iOS, and Android
  Microsoft Edge for Windows
- Recommended Internet Speed: 5Mbps+
Publication Dates
Release Date: 30/05/2025
Expiration Date: 30/05/2026

Barbara Mcgowan, PhD, MBBS

Michael Crotty, MB, BCh, BAO

Ana Maria Cebrián-Cuenca, MD, PhD

Title

Share on ReachMD